T-Mobile US faces a pivotal moment as aggressive industry pricing and a tempered 2026 financial forecast clash with its robust operational performance and network leadership, prompting a major investor exit and forcing a reevaluation of its growth narrative.
Altria Group names CFO Salvatore Mancuso as its incoming CEO, accelerating its smoke-free transition while taking a massive impairment charge on past investments, signaling a sharp strategic reassessment.
Sources indicate Coterra Energy and Devon Energy are in advanced discussions for a merger that would create a shale giant, raising immediate questions for investors about valuation, future dividends, and the strategic logic behind combining two major players with overlapping portfolios.
Ameris Bancorp's latest financial report reveals a dual narrative: robust net interest income and earnings per share, contrasted with a notable increase in loan charge-offs. While share buybacks and profitability metrics remain supportive, analysts are scrutinizing whether the stock's premium valuation is justified amidst emerging credit risks.
LVMH's recent 0.8% single-day gain to €546.9 offers a glimmer of hope after a period of weaker performance, sparking debate among analysts over whether the market is underestimating the luxury conglomerate's long-term resilience and global footprint.
Solid-state battery developer QuantumScape appoints former NVIDIA CFO Geoffrey Ribar to its board, signaling a strategic shift towards manufacturing discipline and capital allocation as it transitions from R&D to pilot production.
Capgemini faces mounting scrutiny after its U.S. subsidiary signed a contract with Immigration and Customs Enforcement (ICE), sparking ethical debates in France and raising questions about governance risks for the IT consulting giant.
Shares of marketing software firm Zeta Global have tumbled over 10% in a week, sparking debate among investors. While a key valuation model suggests the stock is significantly undervalued, market sentiment remains cautious amid broader tech volatility.
Gatsby Chocolate, the 'healthy' indulgence that captivated Sharks and shoppers alike, has vanished from shelves. We trace its journey from a multi-million dollar deal that never closed to its quiet demise, exploring what went wrong for a once-promising brand.
High Tide Inc. reported record quarterly revenue and profitability in its fiscal Q4 2025, fueled by robust Canadian retail growth. The company outlined aggressive store expansion plans and detailed integration efforts for its new German medical cannabis asset, while also signaling cautious optimism regarding potential U.S. market entry.
First Business Financial Services (FBIZ) reported robust 2025 results, driven by resilient margins and core deposit growth, while detailing a contained credit issue in its commercial real estate portfolio and outlining double-digit growth targets for the coming year.
The equipment rental giant's stock suffered its worst week in recent memory after quarterly results fell short of Wall Street's expectations, compounded by a price target cut from a major bank.
While fully autonomous robotic surgeons remain on the horizon, the foundational technology and data ecosystems being built today are setting the stage for a transformative shift. Two industry giants, Intuitive Surgical and Medtronic, offer investors distinct pathways to capitalize on this evolving landscape.
Seaport Research has lowered its price target for Polaris Inc. (PII) following a strong fourth quarter overshadowed by softer-than-expected forward guidance. The firm maintains a Buy rating, citing the company's market share gains and operational improvements amidst ongoing tariff challenges.
E-commerce accelerator Orva appoints former Famous Footwear executive Jason Short as SVP to spearhead growth of its athletic and performance footwear portfolio, leveraging his three decades of industry relationships.
Despite posting solid revenue and profit growth for its final quarter of 2025, Roper Technologies' stock fell sharply this week after its guidance for the coming year fell short of Wall Street's expectations, highlighting the challenges for diversified software firms in an AI-dominated market.
Bank of America raises its price target on Chevron (CVX) to $188, maintaining a Buy rating, as geopolitical tensions and a planned ramp-up of Venezuelan crude exports bolster the energy giant's near-term outlook.
New CMS reimbursement rates are pressuring Medicare Advantage profits, sending shares of Humana and CVS Health lower. We analyze whether the sell-off presents a buying opportunity for dividend investors or signals deeper structural challenges.
A catastrophic landslide at a major coltan mine in rebel-held eastern Congo has killed hundreds of informal miners, casting a harsh light on the deadly human cost behind the global tech supply chain.
RBC Capital reaffirms its Outperform rating on UnitedHealth Group, citing management's commitment to long-term earnings targets, even as a lower-than-expected Medicare Advantage rate proposal triggers a sharp sell-off in the health insurer's shares.
